When I sat down with Arvind Sivaramakrishnan, CTO for Asia Healthcare Holdings for this podcast, I expected a discussion about AI, predictive analytics, and the next frontier of clinical technology. Instead, what I got was a sharp recalibration of priorities. He wasn’t dismissive of technology—but he was deeply sceptical of how hospitals are currently investing in it. And his scepticism wasn’t philosophical. It was financial. What was surprising was how automation drives hospital valuation.
I opened by asking him what technology capabilities truly influence hospital valuations today. His answer was disarmingly simple. If your foundational systems are weak, nothing else matters. He wasn’t impressed by shiny dashboards or AI pilots layered on fragile infrastructure. For investors, the first filter is operational clarity. Is the Hospital Information System robust? Is the revenue cycle clean? Can leadership see real-time numbers without reconciliation gymnastics? If the basics aren’t solid, advanced tools don’t increase valuation—they increase risk. This was a similar insight in my discussion with Sudeep Dey earlier in the series.
I pushed him further. Surely clinical technology improves care and, therefore, enterprise value? His response was uncomfortable but honest. Most hospitals, he argued, are not even extracting value from what they already own. They are layering intelligence on top of broken workflows. Predictive systems are being piloted in environments where discharge summaries are delayed and billing errors surface weeks later. From an investor’s lens, that isn’t innovation. It’s inefficiency with a tech label.
Then he said something that reframed the entire discussion: healthcare must operate 25/8. Not just 24/7. Twenty-five by eight. What he meant was operational continuity beyond human limitation. Hospitals lose margin in the gaps—when claims sit idle, when scheduling stalls, when processes pause because administrators go home. Automation, in his view, is not a futuristic ambition. It is a structural necessity. A hospital that operates seamlessly outside working hours is inherently more valuable than one that relies on manual continuity.
When we spoke about due diligence, he was equally direct. Investors now assume digital hygiene. A functioning HIS, interoperable systems, cyber resilience, standardised workflows—these are entry criteria, not differentiators. If these are missing, valuation compresses because uncertainty rises. Capital dislikes unpredictability. His challenge to boards was sharp: why invest in advanced clinical layers when your billing system cannot reconcile in real time?
Where he became most animated was around automation—not robotic surgery, but administrative and workflow automation. Claims processing. OT scheduling. Pharmacy management. Capacity optimisation. He described automation as EBITDA insurance. Labour costs are rising, and variability is increasing. Automation reduces dependence on human inconsistency and protects margins over time. In a private equity framework, stability commands multiples.
When I asked him what technologies would command premiums by 2030, he didn’t default to AI diagnostics. He spoke about integrated operational platforms, predictive capacity management, intelligent scheduling engines, and systems that eliminate revenue leakage. Not glamorous. But scalable. In his framework, the next valuation uplift will come from invisible infrastructure rather than visible gadgets.
As someone deeply invested in the intersection of clinical quality, technology, and enterprise value, I found this conversation grounding. It forces an uncomfortable introspection. Are healthcare leaders investing to look advanced, or to become operationally resilient? Arvind’s stance is not anti-technology. It is anti-immaturity. Strengthen the foundation. Standardise processes. Install a powerful HIS. Automate relentlessly. Then layer intelligence.
The hospitals that command premium valuations in the next decade may not be the most technologically flashy. They will be the most operationally disciplined. And in a capital-driven ecosystem, discipline—not glamour—wins. And simply how automation drives hospital valuation.
